Why the study?
The impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular cardiomyopathy was unknown.
Does the 2019 ARVC risk model accurately predict ventricular arrhythmias across different genotypes in patients with ARVC?
Does the 2019 ARVC risk model accurately predict ventricular arrhythmias across different genotypes in patients with ARVC?
No takes yet. Share an insight, caveat, or question.
Genotype may modify 2019 ARVC risk model performance; hypothesis-generating and requires prospective validation before clinical use.
Protonotarios et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: